Skip to main content
Clinical Trials/NCT00784069
NCT00784069CompletedPhase 3

Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Breeze Pocket BR.

Sanofi1 site in 1 country27 target enrollmentStarted: October 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Sanofi
Enrollment
27
Locations
1
Primary Endpoint
To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd Breeze Pocket BR.

Study Overview

Brief Summary

To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd Breeze (Lactic Acid) Pocket BR.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Experimental

Lactic Acid (Dermacyd Breeze)

Intervention: Lactic Acid (Drug)

Outcomes

Primary Outcomes

To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd Breeze Pocket BR.

Time Frame: Throughout the study

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sanofi
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials